Verso (VRS) versus Its Competitors Head-To-Head Comparison

Verso (NYSE: VRS) is one of 22 public companies in the “PAPER” industry, but how does it contrast to its rivals? We will compare Verso to similar businesses based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, risk and earnings.

Profitability

How to Become a New Pot Stock Millionaire

This table compares Verso and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Verso -1.22% -4.83% -1.61%
Verso Competitors 18.25% 10.77% 3.69%

Insider and Institutional Ownership

82.2% of Verso shares are owned by institutional investors. Comparatively, 64.8% of shares of all “PAPER” companies are owned by institutional investors. 4.2% of Verso shares are owned by insiders. Comparatively, 5.6% of shares of all “PAPER” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Verso and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Verso $2.46 billion -$30.00 million -18.06
Verso Competitors $5.69 billion $1.15 billion 14.90

Verso’s rivals have higher revenue and earnings than Verso. Verso is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and recommmendations for Verso and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Verso 0 0 2 0 3.00
Verso Competitors 128 473 531 31 2.40

Verso currently has a consensus price target of $27.00, suggesting a potential upside of 71.87%. As a group, “PAPER” companies have a potential upside of 6.41%. Given Verso’s stronger consensus rating and higher possible upside, equities analysts clearly believe Verso is more favorable than its rivals.

Volatility & Risk

Verso has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Verso’s rivals have a beta of 0.79, indicating that their average share price is 21% less volatile than the S&P 500.

Summary

Verso rivals beat Verso on 8 of the 13 factors compared.

About Verso

Verso Corporation is a producer of coated papers, which are used in magazines, catalogs, advertising brochures and annual reports, among other media and marketing publications. The Company operates through two segments: paper and pulp. The Paper segment includes paper products, which are used in media and marketing applications, including catalogs, magazines, and commercial printing applications, such as advertising brochures, annual reports and direct-mail advertising. The Pulp segment includes pulp products, which are used to manufacture printing, writing, and specialty paper grades and tissue products. The Company produces a range of products, ranging from coated freesheet and coated groundwood, to inkjet and digital paper, supercalendered papers and uncoated freesheet. It also produces and sells market kraft pulp, which is used to manufacture printing and writing paper grades and tissue products. The Company also produces and sells Northern Bleached Hardwood Kraft (NBHK) pulp.

Receive News & Ratings for Verso Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verso and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Antero Resources  Given a $22.00 Price Target at Jefferies Group
Antero Resources Given a $22.00 Price Target at Jefferies Group
Royal Bank of Canada Reiterates $43.00 Price Target for Masco
Royal Bank of Canada Reiterates $43.00 Price Target for Masco
Harvest Capital Credit  Major Shareholder Jmp Group Llc Buys 1,901 Shares of Stock
Harvest Capital Credit Major Shareholder Jmp Group Llc Buys 1,901 Shares of Stock
Landmark Bancorp  Insider Patrick L. Alexander Sells 400 Shares
Landmark Bancorp Insider Patrick L. Alexander Sells 400 Shares
Sapiens International  Stock Rating Upgraded by Zacks Investment Research
Sapiens International Stock Rating Upgraded by Zacks Investment Research
Q2 2018 Earnings Estimate for Amgen Issued By William Blair
Q2 2018 Earnings Estimate for Amgen Issued By William Blair


© 2006-2018 Ticker Report. Google+.